PR Newswire - HanAll Biopharma Reports Q1 2024 Financial Results...
Delivered solid performance to start 2024, with record-breaking first quarter revenue of 34.1 billion KRW. Strong sales momentum continued from key products, funding investme...
Read More

ภาษาไทย
English